# LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women

> **NCT05303636** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Insud Pharma** · enrollment: 1536 (actual)

## Conditions studied

- Change in Bone Mineral Density
- Bone Loss

## Interventions

- **DRUG:** drospirenone 4 mg oral tablet or drospirenone 3.5 mg chewable tablet

## Key facts

- **NCT ID:** NCT05303636
- **Lead sponsor:** Insud Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-03-28
- **Primary completion:** 2027-12
- **Final completion:** 2028-06
- **Target enrollment:** 1536 (ACTUAL)
- **Last updated:** 2026-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05303636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05303636, "LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05303636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*